BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 20573444)

  • 21. Activation of beta-catenin by hypoxia in hepatocellular carcinoma contributes to enhanced metastatic potential and poor prognosis.
    Liu L; Zhu XD; Wang WQ; Shen Y; Qin Y; Ren ZG; Sun HC; Tang ZY
    Clin Cancer Res; 2010 May; 16(10):2740-50. PubMed ID: 20460486
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MiR-122/cyclin G1 interaction modulates p53 activity and affects doxorubicin sensitivity of human hepatocarcinoma cells.
    Fornari F; Gramantieri L; Giovannini C; Veronese A; Ferracin M; Sabbioni S; Calin GA; Grazi GL; Croce CM; Tavolari S; Chieco P; Negrini M; Bolondi L
    Cancer Res; 2009 Jul; 69(14):5761-7. PubMed ID: 19584283
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mutant p53 expression enhances drug resistance in a hepatocellular carcinoma cell line.
    Chan KT; Lung ML
    Cancer Chemother Pharmacol; 2004 Jun; 53(6):519-26. PubMed ID: 15004724
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Targeting of X-linked inhibitor of apoptosis protein or survivin by short interfering RNAs sensitize hepatoma cells to TNF-related apoptosis-inducing ligand- and chemotherapeutic agent-induced cell death.
    Yamaguchi Y; Shiraki K; Fuke H; Inoue T; Miyashita K; Yamanaka Y; Saitou Y; Sugimoto K; Nakano T
    Oncol Rep; 2005 Nov; 14(5):1311-6. PubMed ID: 16211302
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A hepatocellular carcinoma-specific adenovirus variant, CV890, eliminates distant human liver tumors in combination with doxorubicin.
    Li Y; Yu DC; Chen Y; Amin P; Zhang H; Nguyen N; Henderson DR
    Cancer Res; 2001 Sep; 61(17):6428-36. PubMed ID: 11522637
    [TBL] [Abstract][Full Text] [Related]  

  • 26. N-myc downstream regulated 1 gene and its place in the cellular machinery.
    Kitowska A; Pawełczyk T
    Acta Biochim Pol; 2010; 57(1):15-21. PubMed ID: 20300662
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hepatitis B virus X protein overcomes the growth-inhibitory potential of retinoic acid by downregulating retinoic acid receptor-beta2 expression via DNA methylation.
    Jung JK; Park SH; Jang KL
    J Gen Virol; 2010 Feb; 91(Pt 2):493-500. PubMed ID: 19828754
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Induction of glutathione transferase in insulin-like growth factor type I receptor-overexpressed hepatoma cells.
    Lee JY; Han CY; Yang JW; Smith C; Kim SK; Lee EY; Kim SG; Kang KW
    Mol Pharmacol; 2007 Oct; 72(4):1082-93. PubMed ID: 17615245
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Different levels of p53 induced either apoptosis or cell cycle arrest in a doxycycline-regulated hepatocellular carcinoma cell line in vitro.
    Lai PB; Chi TY; Chen GG
    Apoptosis; 2007 Feb; 12(2):387-93. PubMed ID: 17191126
    [TBL] [Abstract][Full Text] [Related]  

  • 30. NDRG1 contributes to retinoic acid-induced differentiation of leukemic cells.
    Chen S; Han YH; Zheng Y; Zhao M; Yan H; Zhao Q; Chen GQ; Li D
    Leuk Res; 2009 Aug; 33(8):1108-13. PubMed ID: 19046768
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MicroRNA-122 sensitizes HCC cancer cells to adriamycin and vincristine through modulating expression of MDR and inducing cell cycle arrest.
    Xu Y; Xia F; Ma L; Shan J; Shen J; Yang Z; Liu J; Cui Y; Bian X; Bie P; Qian C
    Cancer Lett; 2011 Nov; 310(2):160-9. PubMed ID: 21802841
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of the Fas/FasL pathway in combination therapy with interferon-alpha and fluorouracil against hepatocellular carcinoma in vitro.
    Nakamura M; Nagano H; Sakon M; Yamamoto T; Ota H; Wada H; Damdinsuren B; Noda T; Marubashi S; Miyamoto A; Takeda Y; Umeshita K; Nakamori S; Dono K; Monden M
    J Hepatol; 2007 Jan; 46(1):77-88. PubMed ID: 17045692
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transfection of Smac sensitizes tumor cells to etoposide-induced apoptosis and eradicates established human hepatoma in vivo.
    Zhao J; Jin J; Zhang X; Shi M; Dai J; Wu M; Wang R; Guo Y
    Cancer Gene Ther; 2006 Apr; 13(4):420-7. PubMed ID: 16211087
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transcriptional analysis of doxorubicin-induced cytotoxicity and resistance in human hepatocellular carcinoma cell lines.
    Wang J; Chan JY; Fong CC; Tzang CH; Fung KP; Yang M
    Liver Int; 2009 Oct; 29(9):1338-47. PubMed ID: 19627484
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Relationship between expression of Smac and Survivin and apoptosis of primary hepatocellular carcinoma.
    Bao ST; Gui SQ; Lin MS
    Hepatobiliary Pancreat Dis Int; 2006 Nov; 5(4):580-3. PubMed ID: 17085346
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of TNF-related apoptosis-inducing ligand in human hepatocellular carcinoma.
    Shiraki K; Yamanaka T; Inoue H; Kawakita T; Enokimura N; Okano H; Sugimoto K; Murata K; Nakano T
    Int J Oncol; 2005 May; 26(5):1273-81. PubMed ID: 15809718
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Glycolysis module activated by hypoxia-inducible factor 1alpha is related to the aggressive phenotype of hepatocellular carcinoma.
    Hamaguchi T; Iizuka N; Tsunedomi R; Hamamoto Y; Miyamoto T; Iida M; Tokuhisa Y; Sakamoto K; Takashima M; Tamesa T; Oka M
    Int J Oncol; 2008 Oct; 33(4):725-31. PubMed ID: 18813785
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Egr-1 mediates hypoxia-inducible transcription of the NDRG1 gene through an overlapping Egr-1/Sp1 binding site in the promoter.
    Zhang P; Tchou-Wong KM; Costa M
    Cancer Res; 2007 Oct; 67(19):9125-33. PubMed ID: 17909017
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Down-regulation of phospho-Akt is a major molecular determinant of bortezomib-induced apoptosis in hepatocellular carcinoma cells.
    Chen KF; Yeh PY; Yeh KH; Lu YS; Huang SY; Cheng AL
    Cancer Res; 2008 Aug; 68(16):6698-707. PubMed ID: 18701494
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Andrographolide enhances 5-fluorouracil-induced apoptosis via caspase-8-dependent mitochondrial pathway involving p53 participation in hepatocellular carcinoma (SMMC-7721) cells.
    Yang L; Wu D; Luo K; Wu S; Wu P
    Cancer Lett; 2009 Apr; 276(2):180-8. PubMed ID: 19097688
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.